AIDS 2026: PrEP efficacy depends on adherence not biology – PrEP access depends on politics
18 August 2026. Related: Conference reports, HIV prevention and transmission.
Intl AIDS 26th Rio 2026
AIDS 2026: Free access to opening ceremony and rapporteur summaries
17 August 2026. Related: Conference reports.
AIDS 2026: The promise of bNAbs in HIV cure-related research in chronic infection
17 August 2026. Related: Conference reports, Cure-related research, Basic science and immunology.
AIDS 2026: UNAIDS special report publishes data to 2025
13 August 2026. Related: Conference reports, Treatment access.
AIDS 2026: New HIV drugs in the ART pipeline
4 August 2026. Related: Conference reports, Antiretrovirals.
AIDS 2026: Activists challenge US government’s claims to manage PEPFAR
27 July 2026. Related: Conference reports, Treatment access, Activism & advocacy.
Merck announces alimatravir access programme ahead of AIDS 2026
24 July 2026. Related: Early access, Conference reports, HIV prevention and transmission.
AIDS 2026: High efficacy continues in open label extensions to lenacapavir phase 3 PrEP studies
21 July 2026. Related: Conference reports, HIV prevention and transmission.
Featured AIDS 2026: Programme highlights to look out for
20 July 2026. Related: Special reports, Conference reports, Treatment access.